Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 13, 2020 07:00 ET | Source: Mateon Therapeutics, Inc.

Mateon Therapeutics to fund observational studies of Artemisinin in developing countries.

Agoura Hills, California, July 13, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics (OTCQB: MATN), a leading developer of TGF-β therapeutics, announced today that it will fund observational studies for...